AI reads your Heart's electrical signals to spot hidden valve trouble

NCT ID NCT06580158

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study at Mayo Clinic is testing whether artificial intelligence can help standard electrocardiograms (ECGs) detect two common heart valve problems: aortic stenosis and diastolic dysfunction. Researchers will enroll 2000 adults aged 60 and older who are already scheduled for an ECG. If the AI flags a potential issue, participants will get a focused ultrasound to confirm the diagnosis. The goal is to see if this AI tool can improve early detection, especially in places where advanced heart imaging is not readily available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-ECG Dashboard (device) and point-of-care ultrasound (diagnostic test)
What this could lead to
If successful, this could make it easier and faster to spot serious heart valve problems using a simple ECG, especially in areas with limited access to specialists.
What could go wrong
This is an early-stage study testing how well the AI works in real clinics. The AI may miss some cases or flag false alarms, and the ultrasound confirmation depends on image quality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.